Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
08/2002
08/01/2002US20020103357 Nucleotide sequences coding enzymatic polypeptide for use in the generation of preferential amino acids, medicines and human nutrients
08/01/2002US20020103351 32146 and 57259, novel human transporters and uses therefor
08/01/2002US20020103340 Rab proteins
08/01/2002US20020103337 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/01/2002US20020103336 Cloning of chicken anemia dna
08/01/2002US20020103121 Amino acid sequence of residues 163-199 used to induce apoptosis in a cell
08/01/2002US20020103115 Useful in the development of human therapeutics and diagnostic compositions and methods
08/01/2002US20020102726 Which forms a reconstructed epidermis, used to test various factors on human skin equivalent, such as drugs, cosmetics, surfactants and detergents
08/01/2002US20020102722 Lac shuttle vectors
08/01/2002US20020102712 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of viral diseases
08/01/2002US20020102711 Polypeptide for use in the treatment of cancer and immunological
08/01/2002US20020102707 Nucleotide sequences coding polypeptide for use in the treatment of sexual disorders
08/01/2002US20020102702 Enzymatic polypeptide for use in the detergents
08/01/2002US20020102698 Gene encoding alkaline liquefying alpha-amylase
08/01/2002US20020102697 Genes encoding exopolysaccharide production
08/01/2002US20020102696 Recombinant thermostable enzyme which forms non-reducing saccharide from reducing amylaceous saccharide
08/01/2002US20020102691 Enzymatic polypeptide for use in treatment and prevention of, heart liver and inflammatory disorders
08/01/2002US20020102690 Genes involved in isoprenoid compound production
08/01/2002US20020102688 Nucleotide sequences coding polypeptide for use as anticoagulant and antiseptic
08/01/2002US20020102684 Human phospholipase inhibitor
08/01/2002US20020102680 Nucleotide sequences coding enzymatcic polypeptide for use in paper making and cleaning contact lenses
08/01/2002US20020102676 Nucleotide sequences coding membrane proteins for use in cancer therapy
08/01/2002US20020102670 DNA coding for protein which confers on bacterium Escherichia coli resistance to L-homoserine, and method for producing L-amino acids
08/01/2002US20020102655 Simultaneous expression of both the heterologous protein, including functional membrane proteins, and a means for compartmentalizing or sequestering of the protein
08/01/2002US20020102653 DNA coding for human cell surface antigen
08/01/2002US20020102652 Polypeptide for use in the diagnosis, prevention and treatment of tumors and autoimmune diseases
08/01/2002US20020102651 Novel B7-4 molecules and uses therefor
08/01/2002US20020102649 Human transport protein homologs
08/01/2002US20020102647 Nucleotide sequences coding membrane protein for use in treatment of nervous system disorders and arthritis
08/01/2002US20020102645 Novel member of the lysyl oxidase gene family
08/01/2002US20020102643 Dorsal tissue affecting factor and compositions
08/01/2002US20020102642 Nuclelotide sequences coding preferential protein for use in therapeutic, diagnostic and medical imaging
08/01/2002US20020102640 Nucleotide sequences coding preferential protein for use in the diagnosis, prevention and treatment of cancer
08/01/2002US20020102636 Promoter can regulate gene expression under various carbohydrate conditions; vector for transformation of a foreign gene or R. oryzae
08/01/2002US20020102635 Methods for making and using a thermophilic enzyme as a beta-glycosidase
08/01/2002US20020102634 Human stanniocalcin-alpha
08/01/2002US20020102633 Polypeptide for use in the treatment bone disorders and osteoarthritis
08/01/2002US20020102618 Drosophila derived receptors of the steroid receptor superfamily
08/01/2002US20020102604 Full-length human cDNAs encoding potentially secreted proteins
08/01/2002US20020102603 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/01/2002US20020102569 Nucleotide sequences for use in the detection, classificataions, treatment and evaluation of cancer therapies
08/01/2002US20020102560 Nucleotide sequences coding enzymatic polypeptide for use in treatment metastasis and tumors
08/01/2002US20020102540 Functional dna clone for hepatitis c virus (hcv) and uses thereof
08/01/2002US20020102276 For diagnosis, therapy and prophylaxis of Neisseria meningitidis infection; vaccine
08/01/2002US20020102270 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/01/2002US20020102269 Contacting a parental Helicobacter with molecule in biological sample, testing and comparing response to extracellular pH and sensitivity to acidity of parental strain to a strain deficient in UreI; selecting molecule
08/01/2002US20020102252 Novel isoforms of human pregnancy-associated protein-E
08/01/2002DE10110760A1 Neue für das otsA-Gen kodierende Nukleotidsequenzen New coding for the otsA gene nucleotide sequences
08/01/2002DE10101962A1 DNA-Sequenz mit regulatorischen Bereichen zur Expression von Proteinen DNA sequence with regulatory regions for expression of proteins
08/01/2002DE10101793A1 Verwendung von SLPI zur Behandlung chronisch-entzündlicher Darmerkrankungen Use of SLPI in the treatment of chronic inflammatory bowel disease
08/01/2002DE10101501A1 Verfahren zur fermentativen Herstellung von Pantothensäure A process for the fermentative production of pantothenic acid
08/01/2002CA2442602A1 Probiotic compounds derived from lactobacillus casei strain ke01
08/01/2002CA2440703A1 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
08/01/2002CA2436091A1 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
08/01/2002CA2435888A1 Method of preparing biological materials and preparation produced using same
08/01/2002CA2435776A1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/01/2002CA2435622A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/01/2002CA2435047A1 Constitutively desensitized g protein-coupled receptors
08/01/2002CA2433681A1 Sulfatases and methods of use thereof
08/01/2002CA2432134A1 Adenylate cyclases
08/01/2002CA2431493A1 Aminoacyl trna synthetases
08/01/2002CA2431144A1 Cell adhesion proteins
08/01/2002CA2430762A1 Colon cancer marker
08/01/2002CA2430743A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
08/01/2002CA2429779A1 Adipocyte complement related protein zacrp13
08/01/2002CA2429397A1 Methods and means for producing efficient silencing construct using recombinational cloning
08/01/2002CA2427676A1 Dna encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor, cells transformed therewith, and recombinant cell line expressing a human alpha and beta subunits of neuronal nicotinic acetylcholine receptor
08/01/2002CA2427647A1 Nucleic acid modification enzymes
08/01/2002CA2426102A1 Method of diagnosing and treating cartilaginous disorders
07/2002
07/31/2002EP1227324A2 Har A polypeptides and nucleic acids and related methods and uses thereof
07/31/2002EP1227323A1 Non-A, non-B hepatitis virus antigen, diagnostic methods and vaccines
07/31/2002EP1227158A1 Method for degrading polylactate resins
07/31/2002EP1227155A1 Process for producing ubiquinone-10
07/31/2002EP1227154A2 Bacillus thuringiensis strains active against lepidopteran and coleopteran pests
07/31/2002EP1227152A1 Bacterial strain and genome of bifidobacterium
07/31/2002EP1227147A2 Recombinational cloning using engineered recombination sites
07/31/2002EP1226884A2 Decontamination bag for soil
07/31/2002EP1226441A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies
07/31/2002EP1226436A2 Universal fluorescent sensors
07/31/2002EP1226435A1 Axor35, a g-protein coupled receptor
07/31/2002EP1226277A2 A method for high-density microarray mediated gene expression profiling
07/31/2002EP1226267A1 Process for producing a product containing antihypertensive tripeptides
07/31/2002EP1226265A2 Bioproduction of para-hydroxycinnamic acid
07/31/2002EP1226263A1 Invasive bacterial vectors for expressing alphavirus replicons
07/31/2002EP1226262A2 Regeneration
07/31/2002EP1226257A2 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins
07/31/2002EP1226250A2 Gpcr-kd5 polypeptides and dna sequences thereof
07/31/2002EP1226249A2 Follistatin-related protein zfsta4
07/31/2002EP1226248A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response
07/31/2002EP1226247A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences
07/31/2002EP1226246A1 Polypeptides with expanded primary signalling motifs
07/31/2002EP1226245A2 Hybrid adaptor receptors
07/31/2002EP1226244A2 Polypeptides with non-natural primary signalling motifs
07/31/2002EP1226243A2 Nucleic acid molecules derived from rat brain and programmed cell death models
07/31/2002EP1226236A1 Polypeptides having glucanotransferase activity and nucleic acids encoding same
07/31/2002EP1226231A1 19 human secreted proteins
07/31/2002EP1226230A1 Lactobacillus helveticus producing antihypertensive di- and tripeptides
07/31/2002EP1226229A1 Method of freeze-drying different microorganisms
07/31/2002EP1226227A2 Method for cultivating cells, a membrane module, utilization of a membrane module and reaction system for cultivation of said cells
07/31/2002EP1226177A2 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use